СУЧАСНІ МЕТОДИ РЕПРОДУКТИВНО МЕДИЦИНИ

The level of modern science can quite quickly identify the cause of infertility, but eliminating it is extremely difficult, especially when it comes to problem insemination. Very important and fundamental step in treating infertility is the introduction into clinical practice new methods of artificial insemination technology.Современная медицина позволяет достаточно быстро выявить причину бесплодия, но устранение ее и достижение желаемой беременности является чрезвычайно сложным процессом, особенно, когда речь идет об оплодотворении. Очень важным и принципиальным этапом влечении бесплодия является введение в клиническую практику новых методов вспомогательных репродуктивныхтехнологий (ДРТ), которые дают возможность реализовать функцию детороджения при различных заболеваниях, восстановление фертильности при которых ранее считалось невозможным.Сучасна медицина дає можливість достатньо швидко виявити причину безпліддя, але усунення та досягнення бажано вагітності є надзвичайно складним процесом, особливо, коли мова іде про запліднення. Дуже важливим та принциповим етапом в лікуванні безпліддя є введення в клінічну практику нових методів допоміжних репродуктивних технологій (ДРТ), які дають змогу реалізувати функцію дітонародження при різних захворюваннях, відновлення фертильності при яких раніше вважалось неможливим

Генетическая специфичность белоголовой украинской породы по гену BоLA-DRB3

The study of the genetic specificity of local breeds is a promising direction in the context of preserving the biodiversity of cattle breeds in the world. The purpose of research was to analyze the allelic polymorphism of the BoLA-DRB3 gene of the White-Headed Ukrainian breed. The study was carried out with blood samples from 49 animals (11 bulls and 38 cows) of this breed. The allelic spectrum of the BoLA-DRB3 gene was detected based on two-step PCR (primers HLO-30, HLO-31 and HLO-32). Restriction was performed with endonucleases RsaI, HaeIII, BstYI. Restriction fragments were separated by electrophoresis in 9-12 % polyacrylamide gel. According to the test results, 29 alleles were detected. Seven alleles (*03, *11, *13, *15, *22, *23 and *24) were determined with a frequency of over 5 %, that was 65.3 % of the allele pool of the breed. The most common was allele *24 with a frequency of 15.3%. In the experimental sample, 37 genotypes were identified. The predominant variant was *11/*24 (16.2%). A slight excess of heterozygotes was detected (Fis = – 0.035). White-Headed Ukrainian breed is characterized by a significant level of differentiation (or specificity) according to the BoLA-DRB3 gene (Wright fixation index He = 0.959, Shannon-Wiener index H` = 2.93), that confirms the thesis of the important role of local breeds in preserving the biodiversity of genetic resources of cattle.Изучение генетической специфичности локальных пород – одно из перспективных направлений в контексте сохранения биоразнообразия пород крупного рогатого скота в мире. Цель исследования – определение и анализ аллельного полиморфизма гена BoLA-DRB3 белоголовой украинской породы. Изучение проведено на образцах крови 49 животных (11 быков и 38 коров) этой породы. Аллельный спектр гена BoLA-DRB3 определяли на основе двухступенчатой ПЦР (праймеры HLO-30, HLO-31 и HLO-32). Рестрикцию проводили эндонуклеазами RsaI, HaeIII, BstYI. Фрагменты рестрикции разделяли электрофорезом в 9–12%-ном полиакриламидном геле. В результате исследований обнаружено 29 аллелей. Семь аллелей (*03, *11, *13, *15, *22, *23 и *24) определялись с частотой более 5 %, что составляло 65,3 % аллельного фонда породы. Наиболее распространенным с частотой 15,3 % выявлялся аллель *24. В экспериментальной выборке идентифицировано 37 генотипов. Преобладающий вариант – *11/*24 (16,2 %). Выявлен небольшой избыток гетерозигот (FIS = -0,035). Характерной особенностью белоголового украинского скота является существенная дифференциация (или специфичность) по гену BoLA-DRB3 (индекс фиксации Райта He = 0,959, индекс Шеннона-Винера H` = 2,93), что подтверждает тезис о важной роли местных пород в сохранении биоразнообразия генетических ресурсов крупного рогатого скота

The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma

Background: Recently, CD4 + IL-17A + T helper 17 (Th17) cells were identified and reported in several diseased states, including autoimmunity, infection and various peripheral nervous system tumors. However, the presence of Th17 in gliaderived tumors of the central nervous system has not been studied. Methodology/Principal Findings: In this report, we demonstrate that mRNA expression for the Th17 cell cytokine IL-17A, as well as Th17 cells, are present in human glioma. The mRNA expression for IL-17A in glioma was recapitulated in an immunocompetent mouse model of malignant glioma. Furthermore, the presence of Th17 cells was confirmed in both human and mouse glioma. Interestingly, some Th17 cells present in mouse glioma co-expressed the Th1 and Th2 lineage markers, IFN-c and IL-4, respectively, but predominantly co-expressed the Treg lineage marker FoxP3. Conclusions: These data confirm the presence of Th17 cells in glia-derived CNS tumors and provide the rationale for further investigation into the role of Th17 cells in malignant glioma

Measurement of the Bottom-Strange Meson Mixing Phase in the Full CDF Data Set

We report a measurement of the bottom-strange meson mixing phase \beta_s using the time evolution of B0_s -> J/\psi (->\mu+\mu-) \phi (-> K+ K-) decays in which the quark-flavor content of the bottom-strange meson is identified at production. This measurement uses the full data set of proton-antiproton collisions at sqrt(s)= 1.96 TeV collected by the Collider Detector experiment at the Fermilab Tevatron, corresponding to 9.6 fb-1 of integrated luminosity. We report confidence regions in the two-dimensional space of \beta_s and the B0_s decay-width difference \Delta\Gamma_s, and measure \beta_s in [-\pi/2, -1.51] U [-0.06, 0.30] U [1.26, \pi/2] at the 68% confidence level, in agreement with the standard model expectation. Assuming the standard model value of \beta_s, we also determine \Delta\Gamma_s = 0.068 +- 0.026 (stat) +- 0.009 (syst) ps-1 and the mean B0_s lifetime, \tau_s = 1.528 +- 0.019 (stat) +- 0.009 (syst) ps, which are consistent and competitive with determinations by other experiments.Comment: 8 pages, 2 figures, Phys. Rev. Lett 109, 171802 (2012

Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

PURPOSE Diffuse intrinsic pontine glioma (DIPG) is among the deadliest of pediatric brain tumors. Radiotherapy is the standard-of-care treatment for DIPG, but offers only transient relief of symptoms for patients with DIPG without providing significant survival benefit. Oncolytic virotherapy is an anticancer treatment that has been investigated for treating various types of brain tumors. EXPERIMENTAL DESIGN Here, we have explored the use of mesenchymal stem cells (MSC) for oncolytic virus (OV) delivery and evaluated treatment efficacy using preclinical models of DIPG. The survivin promoter drives the conditional replication of OV used in our studies. The efficiency of OV entry into the cells is mediated by fiber modification with seven lysine residues (CRAd.S.pK7). Patients' samples and cell lines were analyzed for the expression of viral entry proteins and survivin. The ability of MSCs to deliver OV to DIPG was studied in the context of a low dose of irradiation. RESULTS Our results show that DIPG cells and tumors exhibit robust expression of cell surface proteins and survivin that enable efficient OV entry and replication in DIPG cells. MSCs loaded with OV disseminate within a tumor and release OV throughout the DIPG brainstem xenografts in mice. Administration of OV-loaded MSCs with radiotherapy to mice bearing brainstem DIPG xenografts results in more prolonged survival relative to that conferred by either therapy alone (P < 0.01). CONCLUSIONS Our study supports OV, CRAd.S.pK7, encapsulated within MSCs as a therapeutic strategy that merits further investigation and potential translation for DIPG treatment